Royalty Pharma plc (RPRX) Revenue Growth
Royalty Pharma plc (RPRX) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2021-12-31 | 7.87% |
| 2022-12-31 | -2.28% |
| 2023-12-31 | 5.24% |
| 2024-12-31 | -3.86% |
| 2025-12-31 | 5.06% |
How RPRX compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| EXEL | Exelixis Inc. | 6.98% |
| A | Agilent Technologies Inc. | 6.73% |
| JNJ | Johnson & Johnson | 6.05% |
| IQV | IQVIA Holdings Inc. | 5.87% |
| ABT | Abbott Laboratories | 5.67% |
These are five companies in the same sector as RPRX with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Royalty Pharma plc Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("RPRX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RPRX | $60.85 | -1.73% | 1.70M |
| 3 | ||||
| 4 | ||||
| 5 |